Related Experiment Videos

Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia:

Roeland Huijgen1, Evertine J Abbink, Eric Bruckert

  • 1Department of Vascular Medicine, Academic Medical Centre, Amsterdam, the Netherlands.

Clinical Therapeutics
|May 4, 2010
PubMed

Insights

Adding colesevelam to statin + ezetimibe therapy significantly improved LDL-C levels in familial hypercholesterolemia (FH) patients. This combination was well-tolerated over 12 weeks, offering a new option for managing high cholesterol.

Area of Science:

  • Cardiology
  • Pharmacology
  • Genetics

Background:

  • Familial hypercholesterolemia (FH) significantly elevates cardiovascular risk.
  • Many FH patients do not achieve target LDL-C levels with existing therapies.
  • Intensive combination treatments are often required for FH management.

Purpose of the Study:

  • To evaluate the efficacy and tolerability of adding colesevelam to statin + ezetimibe therapy.
  • To assess the impact on LDL-C and other lipid parameters in FH patients.
  • To determine the safety profile of this combination therapy.

Main Methods:

  • Phase IV, randomized, double-blind, placebo-controlled trial.
  • Enrolled FH patients (18-75 years) with LDL-C >2.5 mmol/L on stable statin + ezetimibe.
  • Assessed LDL-C reduction at 6 and 12 weeks, with secondary lipid outcomes and tolerability.

Main Results:

  • Colesevelam addition resulted in a significant LDL-C reduction of -18.5% at 6 weeks versus placebo.
  • After 12 weeks, LDL-C, total cholesterol, and apoB/apoA-I ratio were significantly reduced with colesevelam.
  • Colesevelam was generally well-tolerated, with similar rates of gastrointestinal adverse events compared to placebo.

Conclusions:

  • Colesevelam is effective in further reducing LDL-C in FH patients inadequately controlled by statin + ezetimibe.
  • The addition of colesevelam demonstrates a favorable tolerability profile.
  • This combination therapy offers a promising strategy for managing FH and reducing cardiovascular risk.
Abstract

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...